Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 21

Lilly Files Six Lawsuits Against Black-Market Retatrutide Sellers

Aug 13, 2026
Eli Lilly and Company has filed six new lawsuits against U.S. entities accused of selling unauthorized retatrutide products, escalating the pharmaceutical company's efforts to combat…
Read More...

Ivonescimab Wins China Approval for First-Line Squamous NSCLC

Aug 13, 2026
Summit Therapeutics has announced that its partner Akeso has received marketing authorization from China’s National Medical Products Administration (NMPA) for ivonescimab in combination…
Read More...

Sentynl, Mereo Partner to Advance Oral AATD Lung Disease Therapy

Aug 13, 2026
Sentynl Therapeutics, a U.S.-based biopharmaceutical company and wholly owned subsidiary of Zydus Lifesciences, has entered into an option and license agreement with clinical-stage rare…
Read More...

Infinimmune Raises $75 Million to Advance Antibody Pipeline

Aug 13, 2026
Infinimmune, a biotechnology company developing fully human antibody therapeutics derived directly from the human immune system, has raised $75 million in a Series A financing round to…
Read More...

Remepy Raises $36 Million to Advance Hybrid Drug Pipeline

Aug 13, 2026
Remepy, a biotechnology company developing a new class of medicines that combine prescription drugs with personalized, AI-driven therapeutic applications, has raised $36 million in a…
Read More...

Epicrispr Raises $90 Million to Advance Epigenetic Medicines

Aug 12, 2026
Epicrispr Biotechnologies, a clinical-stage biotechnology company developing programmable epigenetic medicines, has raised $90 million in an oversubscribed Series C financing round to…
Read More...

2nd T-Cell Engager for Autoimmune Disease Summit Returns in 2026 to Advance the Next Wave of…

Aug 11, 2026
Industry leaders from Gilead Sciences, Sanofi, Eli Lilly, Takeda, Bristol Myers Squibb, Novartis and more will gather to address safety, translational predictability, biomarker strategy…
Read More...

Sobi Partners With Innate Pharma on Lacutamab in T-Cell Lymphoma

Aug 11, 2026
Swedish pharmaceutical company Sobi and Innate Pharma have entered into a strategic partnership to advance lacutamab, an investigational treatment for cutaneous T-cell lymphoma (CTCL),…
Read More...

Jazz Pharmaceuticals to Acquire Actio Biosciences for $820 Million

Aug 11, 2026
Jazz Pharmaceuticals has agreed to acquire privately held Actio Biosciences in a deal worth up to $1.32 billion, adding an experimental precision medicine for a rare form of epilepsy to…
Read More...

Innovent to Commercialize Daiichi Sankyo’s Vanflyta in China

Aug 11, 2026
Innovent Biologics and Daiichi Sankyo have signed an exclusive agreement that will give Innovent sole commercialization rights for Vanflyta (quizartinib) in China, expanding the Chinese…
Read More...
Previous 1 … 19 20 21 22 23 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.